Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127721541 | 12772154 | 1 | I | 201210 | 20160912 | 20160922 | 20160922 | EXP | ES-FRESENIUS KABI-FK201606740 | FRESENIUS KABI | VALERA R,LABRADOR A,RUBIO S,CHACON LOPEZ-MUNIZ J,DIAZ PANIAGUA L. PHARMACOLOGICAL APPROACH FOR THE MANAGEMENT OF ADRENOCORTICAL CARCINOMA: A CASE REPORT. EUR-J-CLIN-PHAM 2016;18 (3):199-201. | 16.00 | YR | F | Y | 0.00000 | 20160922 | OT | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127721541 | 12772154 | 1 | PS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | U | 90242 | 800 | MG/M**2 | UNKNOWN | |||||||
| 127721541 | 12772154 | 2 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | U | 90242 | |||||||||||
| 127721541 | 12772154 | 3 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | U | 90242 | |||||||||||
| 127721541 | 12772154 | 4 | SS | CAPECITABINE (Manufacturer unknown) | CAPECITABINE | 1 | Unknown | U | 0 | 800 | MG | UNKNOWN | |||||||
| 127721541 | 12772154 | 5 | SS | CAPECITABINE (Manufacturer unknown) | CAPECITABINE | 1 | U | 0 | |||||||||||
| 127721541 | 12772154 | 6 | SS | CAPECITABINE (Manufacturer unknown) | CAPECITABINE | 1 | U | 0 | |||||||||||
| 127721541 | 12772154 | 7 | C | ERYTHROPOIETIN | ERYTHROPOIETIN | 1 | 0 | ||||||||||||
| 127721541 | 12772154 | 8 | C | PEGFILGRASTIM | PEGFILGRASTIM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127721541 | 12772154 | 1 | Adrenocortical carcinoma |
| 127721541 | 12772154 | 2 | Metastases to lung |
| 127721541 | 12772154 | 3 | Metastases to liver |
| 127721541 | 12772154 | 4 | Adrenocortical carcinoma |
| 127721541 | 12772154 | 5 | Metastases to lung |
| 127721541 | 12772154 | 6 | Metastases to liver |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127721541 | 12772154 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127721541 | 12772154 | Intracardiac thrombus | |
| 127721541 | 12772154 | Leukocytosis | |
| 127721541 | 12772154 | Pancytopenia | |
| 127721541 | 12772154 | Pyrexia | |
| 127721541 | 12772154 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |